Corporate & investor information.
Jardin Pharma Berhad is a Malaysian-incorporated public company operating four specialised entities across the pharmaceutical value chain. This page consolidates corporate, governance and investor-relations information for analysts, partners and prospective shareholders.
A halal pharmaceutical group built for scale.
Jardin Pharma Berhad (JPB) was incorporated in Malaysia under the Companies Act 2016 on 11 May 2021 as a public company. The group operates four subsidiaries — JMSB, TLP, JMD and JPRC — covering manufacturing, premium production, distribution and probiotic research.
Our customer base spans the Malaysian Ministry of Health (under the Bumiputera Adoption Scheme), private hospitals and pharmacy chains, OEM brand owners, and direct consumers via authorised distribution channels and Herbitus.com.
Active export operations include Singapore, with regulatory dossiers prepared for ASEAN, MENA and OIC market expansion.
Operating metrics.
Four entities under Jardin Pharma Berhad.
Founder-led, board-governed.
Jardin Pharma Berhad is led by founders and a board with backgrounds in pharmacy, regulatory affairs, manufacturing and commercial operations.
Detailed leadership profiles, board composition and governance documents are available on request from corporate communications.
For analysts & institutional partners
Financial information, governance documents and corporate announcements for prospective investors, analysts and institutional partners.
Corporate IR contact: admin@jardinpharma.com.my
Available on request.
- Certificate of Incorporation
- Memorandum & Articles of Association
- Group structure chart
- Board composition
- Quality & compliance certificates
- Manufacturing facility documentation
- Product registration evidence (MAL, MDA, NOT)
- Halal certification register
Talk to corporate communications.
For investor questions, document requests, analyst briefings or partnership discussions.
Contact usLatest from Jardin Pharma.
Operational updates, regulatory milestones and corporate announcements.
All news